paclitaxel has been researched along with Dermatitis, Radiation-Induced in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (29.17) | 18.2507 |
2000's | 9 (37.50) | 29.6817 |
2010's | 8 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banner, R; Kahan, J | 1 |
Belum, VR; Dalenc, F; Deslandres, M; Eche, A; Gladieff, L; Lacouture, ME; Lebœuf, NR; Montastruc, M; Roche, H; Sibaud, V; Vigarios, E | 1 |
Anderson, E; Birnbaum, A; Dipetrillo, T; Henderson, D; Joyce, D; Kennedy, T; Puthwala, Y; Rathore, R; Ready, N; Safran, H; Sio, TT; Wanebo, H | 1 |
Beal, K; Damast, S; Elkin, E; Fornier, MN; Ho, AY; Ishill, N; McCormick, B; Montgomery, L | 1 |
Anthony, S; Chen, WC; Cooper, BW; Hanks, SH; Kim, E; Kim, J; Leeming, R; Lyons, JA; Overmoyer, B; Shenk, R; Silverman, P | 1 |
Balabanova, M; Broshtilova, V; Darlenski, R; Gergovska, M; Kazandjieva, J; Márina, S; Stransky, L | 1 |
Fietkau, R; Iro, H; Klautke, G; Kuwert, T; Lell, M; Linke, R; Semrau, S; Uder, M; Waldfahrer, F | 1 |
Brunetti, G; Ruocco, E; Ruocco, V | 1 |
Benezery, K; Lagrange, JL; Magné, N; Namer, M; Otto, J | 1 |
Krempien, R; Piroth, MD; Wannenmacher, M; Zierhut, D | 1 |
Hunter, N; Li, C; Mason, KA; Milas, L; Wallace, S | 1 |
Conzen, SD; Fleming, GF; Heimann, R; Jaskowiak, NT; Kao, J; Masters, GA; Recant, W; Singh, R; Song, DH | 1 |
Deutsch, M; Werner, R | 1 |
De Giorgi, U; Emiliani, E; Frassineti, L; Giannini, M; Giovannini, N; Kopf, B; Marangolo, M; Palazzi, S; Rosti, G; Zumaglini, F | 1 |
Bishop, JF; Phillips, KA; Urch, M | 1 |
Gelmon, K; Shenkier, T | 1 |
Bloomer, WD; Merkel, DE; Raghavan, VT | 1 |
Lillis, P; McCarty, MJ; Peake, MF; Vukelja, SJ | 1 |
Bamberg, M; Bokemeyer, C; Heneka, M; Kanz, L; Lampe, C; Schabet, M | 1 |
Johnson, PJ; Leung, SF; Yeo, W | 1 |
Bavbek, S; Kaytan, E; Kizir, A; Oral, EN; Tenececi, N; Topuz, E; Yöney, A | 1 |
Camidge, DR; Kunkler, IH | 1 |
Aletti, G; Beatrice, S; Carnelli, M; Ferrari, A; Frigerio, L; Garavaglia, E; Mangili, G | 1 |
Giesel, BU; Kutz, GG; Thiel, HJ | 1 |
5 review(s) available for paclitaxel and Dermatitis, Radiation-Induced
Article | Year |
---|---|
Dermatological adverse events with taxane chemotherapy.
Topics: Alopecia; Antineoplastic Agents; Docetaxel; Drug Eruptions; Edema; Humans; Lupus Erythematosus, Cutaneous; Nail Diseases; Paclitaxel; Pigmentation Disorders; Radiodermatitis; Taxoids | 2016 |
[Radiation recall dermatitis after docetaxel and external beam radiotherapy. Report of two cases and review of the literature].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Lobular; Combined Modality Therapy; Docetaxel; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Paclitaxel; Radiodermatitis; Radiotherapy; Taxoids | 2002 |
Angiosarcoma of the breast with delay in diagnosis.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Biopsy; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Early Diagnosis; False Negative Reactions; Fatal Outcome; Female; Hemangiosarcoma; Humans; Lymph Node Excision; Mastectomy, Segmental; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Paclitaxel; Pigmentation Disorders; Radiodermatitis; Radiotherapy, Adjuvant; Telangiectasis | 2004 |
Paclitaxel-induced radiation recall dermatitis.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Radiodermatitis | 1996 |
[Recall dermatitis caused by re-exposure to docetaxel following irradiation of the brain. Case report and review of the literature].
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Clinical Trials as Topic; Combined Modality Therapy; Docetaxel; Drug Eruptions; Female; Humans; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Radiodermatitis; Radiotherapy Dosage; Taxoids | 2001 |
7 trial(s) available for paclitaxel and Dermatitis, Radiation-Induced
Article | Year |
---|---|
Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis.
Topics: Acneiform Eruptions; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Combined Modality Therapy; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiodermatitis; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2010 |
A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carbon Monoxide; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Humans; Lymphatic Irradiation; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Paclitaxel; Pulmonary Diffusing Capacity; Radiodermatitis | 2012 |
Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Mammaplasty; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Radiodermatitis; Wound Healing | 2005 |
Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Epirubicin; Feasibility Studies; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Heart Failure; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiation Pneumonitis; Radiodermatitis; Razoxane; Recombinant Proteins | 2006 |
Radiation-recall dermatitis in a patient treated with paclitaxel.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Middle Aged; Paclitaxel; Radiodermatitis; Recurrence | 1995 |
Preliminary analysis of a phase II study of Paclitaxel and CHART in locally advanced non-small cell lung cancer.
Topics: Adolescent; Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiation Injuries; Radiation-Sensitizing Agents; Radiodermatitis; Retrospective Studies | 1999 |
Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study.
Topics: Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Diarrhea; Drug Administration Schedule; Drug Eruptions; Endometrial Neoplasms; Feasibility Studies; Female; Hematologic Diseases; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Radiation Injuries; Radiation-Sensitizing Agents; Radiodermatitis; Radiotherapy; Radiotherapy, Adjuvant; Risk Factors | 2001 |
12 other study(ies) available for paclitaxel and Dermatitis, Radiation-Induced
Article | Year |
---|---|
A localised skin reaction after chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Drug Eruptions; Endometrial Neoplasms; Erythema; Female; Humans; Middle Aged; Paclitaxel; Radiodermatitis; Spinal Neoplasms | 2018 |
Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carboplatin; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Mastectomy, Modified Radical; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Radiodermatitis; Radiotherapy, Adjuvant; Retrospective Studies | 2010 |
Recall dermatitis after systemic treatment with paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Middle Aged; Paclitaxel; Radiodermatitis; Skin | 2010 |
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early r
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Laryngeal Neoplasms; Leukopenia; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Opportunistic Infections; Paclitaxel; Positron-Emission Tomography; Radiodermatitis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Salvage Therapy; Taxoids; Thrombocytopenia; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 2011 |
Recall phenomena: another facet of the immunocompromised district.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Female; Humans; Paclitaxel; Radiodermatitis | 2013 |
Radiation recall dermatitis from docetaxel.
Topics: Adult; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Female; Humans; Paclitaxel; Radiodermatitis; Radiotherapy, Adjuvant; Recurrence; Taxoids | 2002 |
Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability.
Topics: Adenocarcinoma; Animals; Combined Modality Therapy; Confidence Intervals; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Hair; Infusions, Intravenous; Jejunal Diseases; Mice; Mice, Inbred C3H; Ovarian Neoplasms; Paclitaxel; Polyglutamic Acid; Radiation Injuries; Radiation-Sensitizing Agents; Radiodermatitis; Radiotherapy Dosage; Specific Pathogen-Free Organisms; Taxoids | 2003 |
Paclitaxel and radiation-recall dermatitis.
Topics: Adult; Female; Humans; Middle Aged; Paclitaxel; Radiation Tolerance; Radiodermatitis; Radiotherapy; Recurrence | 1994 |
Taxol and radiation recall dermatitis.
Topics: Adult; Breast Neoplasms; Female; Humans; Paclitaxel; Radiation Tolerance; Radiodermatitis | 1993 |
Paclitaxel-induced radiation recall dermatitis.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Female; Humans; Middle Aged; Paclitaxel; Radiodermatitis; Radiotherapy | 1996 |
Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold.
Topics: Abdominal Muscles; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Eruptions; Female; Humans; Middle Aged; Paclitaxel; Radiodermatitis; Radiotherapy Dosage; Taxoids | 1997 |
Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Middle Aged; Paclitaxel; Radiodermatitis; Recurrence; Taxoids | 2000 |